
|Articles|June 17, 2014
- Precision Diagnostics
- Volume 1
- Issue 1
The Importance of Urine Tests for Mutation Detection
Author(s)Filip Janku, MD, PhD
Filip Janku, MD, PhD, assistant professor, Department of Investigational Cancer Therapeutics, University of Texas, MD Anderson Cancer Center, discusses the importance of having a urine test to detect for cancer mutations.
Advertisement
Filip Janku, MD, PhD, assistant professor, Department of Investigational Cancer Therapeutics, University of Texas, MD Anderson Cancer Center, discusses the importance of having a urine test to detect for cancer mutations.
Learn more about mutational analysis using urinary cell-free DNA > >
Articles in this issue
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Gedatolisib Improves PFS in HR+/HER2-/PIK3CA-WT Advanced Breast Cancer
2
FDA Approves Niraparib/Abiraterone Combo for BRCA2-Mutated mCSPC
3
Imlunestrant Regimens Sustain Efficacy Benefit in ER+/HER2– Breast Cancer
4
Giredestrant/Everolimus Improves PFS Across Subgroups After CDK4/6i in ER+/HER2– Breast Cancer
5










































